Search Results - "Dahlöf, C G"

Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials by Dahlöf, C G, Pascual, J, Dodick, D W, Dowson, A J

“…A meta-analysis of pooled individual patient data from four randomized, placebo-controlled, double-blind trials comparing several doses of almotriptan (n =…”
Get more information

Almotriptan and zolmitriptan in the acute treatment of migraine by Goadsby, P. J., Massiou, H., Pascual, J., Diener, H.-C., Dahlöf, C. G. H., Mateos, V., Dowson, A. J., Raets, I., Cunha, L., Färkkilä, M., Manzoni, G. C.

“…Objective:  To compare almotriptan and zolmitriptan in the treatment of acute migraine. Methods:  This multicentre, double‐blind trial randomized adult…”
Get full text

Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine by Sandrini, G, Dahlöf, C G, Mathew, N, Nappi, G

“…Almotriptan is a 5-HT(1B/1D) receptor agonist, or triptan, indicated for the acute treatment of migraine. It has been shown to be effective and well tolerated…”
Get more information

Migraine patients experience poorer subjective well-being/quality of life even between attacks by Dahlöf, C G, Dimenäs, E

“…The aim of the present study was to compare the general well-being of migraine patients between attacks with that of an age- and sex-matched control group. One…”
Get more information

A Six-Item Short-Form Survey for Measuring Headache Impact: The HIT-6 by M. Kosinski, M. S. Bayliss, J. B. Bjorner, J. E. Ware, Jr, W. H. Garber, A. Batenhorst, R. Cady, C. G. H. Dahlöf, A. Dowson, Tepper, S.

“…Background: Migraine and other severe headaches can cause suffering and reduce functioning and productivity. Patients are the best source of information about…”
Get full text

Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study by Dahlöf, C G H, Hauge, A W, Olesen, J

“…The ability of tonabersat to relieve the symptoms of migraine attacks with or without aura was evaluated in a randomized, double-blind, placebo-controlled,…”
Get more information

Sumatriptan: Pharmacological Basis and Clinical Results by Dahlof, Carl G H

“…SUMMARYSumatriptan was the first selective serotonin (5-HT)1B/1D agonist for the acute treatment of migraine attacks. Apart from the subcutaneous and oral…”
Get full text

Within-patient consistency of response of rizatriptan for treating migraine by DAHLÖF, C. G. H, LIPTON, R. B, MCCARROLL, K. A, KRAMER, M. S, LINES, C. R, FERRARI, M. D

“…To determine the within-patient consistency of response for rizatriptan, a 5-HT(1B/1D) receptor agonist for the acute treatment of migraine. Post hoc analysis…”
Get full text

Sumatriptan Injection and Tablets in Clinical Practice: Results of a Survey of 707 Migraineurs by Dahlöf, Carl G.H., Saiers, Jane

“…This report from the Gothenburg Migraine Clinic in Sweden describes the results of a telephone survey of over 700 patients using open‐label sumatriptan tablets…”
Get full text

Health-related quality of life under six months' treatment of migraine--an open clinic-based longitudinal study by Dahlöf, C G

“…Health-related quality of life (HQL) assessment in the clinical setting have distinguished subjective perceptions (e.g., well-being), signs/symptoms of the…”
Get more information

Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects : a comparison with atenolol by DIMENÄS, E. S, DAHLOÊF, C. G, HEIBEL, B, MOORE, R. G, OLOFSSON, B. K, WESTERGREN, G. E, LUÊCKER, P. W

“…In a double-blind, randomised, cross-over study, the pharmacokinetic/dynamic effects and subjective symptoms of a new controlled-release (CR) formulation of…”
Get full text

Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials by Dahlöf, C G H

“…A migraineur can claim to be an infrequent responder ('non-responder') to an oral triptan independent of which triptan he or she is presently using. Four…”
Get more information

Differences in the subjective well-being and symptoms of normotensives, borderline hypertensives and hypertensives by Dimenäs, E S, Wiklund, I K, Dahlöf, C G, Lindvall, K G, Olofsson, B K, De Faire, U H

“…In this study, previously untreated subjects were randomly recruited from a blood pressure screening programme. After repeated measurement of blood pressure…”
Get more information

Defining quality of life in medicine by Dimenäs, E S, Dahlöf, C G, Jern, S C, Wiklund, I K

“…In recent years, there has been increasing interest in incorporating the concept of "Quality of Life" in the evaluation of medical interventions. The lack of a…”
Get more information

Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists by Carlsson, E, Dahlöf, C G, Hedberg, A, Persson, H, Tångstrand, B

“…The relative inotropic and chronotropic activity of beta-adrenoceptor agonists was studied in the noradrenaline-depleted, anaesthetized cat. Terbutaline, a…”
Get full text

Rizatriptan in the treatment of migraine by Dahlof, Carl G.H., Rapoport, Alan M., Sheftell, Fred D., Lines, Christopher R.

“…Rizatriptan is a selective 5-hydroxytriptamine 1B/1D receptor agonist that was launched in 1998 for the acute treatment of migraine in adults. Based on data…”
Get full text

Re-evaluation of the antimineralocorticoid effect of the spironolactone metabolite, canrenone, from plasma concentrations determined by a new high-pressure liquid-chromatographic method by Dahlöf, C G, Lundborg, P, Persson, B A, Regårdh, C G

Get more information

Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia by Linde, M, Elam, M, Lundblad, L, Olausson, H, Dahlöf, C G H

“…Unpleasant sensory symptoms are commonly reported in association with the use of 5-HT1B/1D-agonists, i.e. triptans. In particular, pain/pressure symptoms from…”
Get more information

Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies? by Dahlöf, C G, Hargreaves, R J

“…This article reviews the pathophysiology and pharmacology of emesis in relation to migraine pathogenesis. Also, the place of antiemetic and gastrointestinal…”
Get more information

How does sumatriptan perform in clinical practice? by Dahlöf, C G

“…The patient's opinion on sumatriptan treatment has been obtained from 351 migraineurs (299F and 52M) by means of a telephone survey. The results are based on…”
Get more information